Stadius Biopharma is an early stage biopharma company working to deliver novel, transformational monoclonal antibody therapeutics for the treatment of life threatening infectious diseases to treat opportunistic pathogens in immuno-compromised patients.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Monoclonal antibodies to Candida spp and Asergillum
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):